Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

14.50
+1.6212.58%
Post-market: 14.870.3700+2.55%19:59 EDT
Volume:12.43M
Turnover:174.91M
Market Cap:1.43B
PE:-2.49
High:14.58
Open:13.22
Low:13.20
Close:12.88
52wk High:39.89
52wk Low:12.73
Shares:98.32M
Float Shares:80.72M
Volume Ratio:2.64
T/O Rate:15.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8279
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-24.22%
PB:-4.90
PE(LYR):-2.49

Loading ...

U.S. Stocks on the MOVE-Gold Miners, Polestar Automotive, Nvidia

Reuters
·
Sep 03

Ultragenyx price target lowered to $28 from $77 at Jefferies

TIPRANKS
·
Sep 03

Wedbush Keeps Their Hold Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 03

Ultragenyx price target lowered to $33 from $103 at Cantor Fitzgerald

TIPRANKS
·
Sep 03

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR)

TIPRANKS
·
Sep 03

Ultragenyx Stock Sinks 47% on Drug Trial Failure. Why Wall Street Isn't Giving up Yet.

Dow Jones
·
Sep 03

U.S. Stocks on the MOVE-Snowflake, Ultragenyx Pharmaceutical, Broadcom

Reuters
·
Sep 03

Top Premarket Decliners

MT Newswires Live
·
Sep 03

Wedbush Adjusts Price Target on Ultragenyx Pharmaceutical to $23 From $30, Maintains Neutral Rating

MT Newswires Live
·
Sep 03

Canaccord Genuity Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 03

Ultragenyx price target lowered to $37 from $83 at Canaccord

TIPRANKS
·
Sep 03

Ultragenyx price target lowered to $25 from $50 at H.C. Wainwright

TIPRANKS
·
Sep 03

Stocks to Watch: Snowflake, Broadcom, HPE, Ultragenyx

Dow Jones
·
Sep 03

Ultragenyx Pharma is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Sep 03

Ultragenyx Pharmaceutical Shares Crash 45% After Angelman Syndrome Drug Trial Disappoints

Trading Random
·
Sep 03

Ultragenyx Pharmaceutical Inc. : Baird Cuts to Neutral Rating; Cuts Target Price to $16 from $40

THOMSON REUTERS
·
Sep 03

Ultragenyx Pharmaceutical Inc. : TD Cowen Cuts Target Price to $18 from $49

THOMSON REUTERS
·
Sep 03

Ultragenyx Pharmaceutical Inc. : Canaccord Genuity Cuts Target Price to $37 from $83

THOMSON REUTERS
·
Sep 03

Ultragenyx downgraded to In Line from Outperform at Evercore ISI

TIPRANKS
·
Sep 03

Evercore ISI downgrades Ultragenyx Pharmaceutical (RARE) to a Hold

TIPRANKS
·
Sep 03